Public Policy

Lilly is committed to participating in and informing healthcare policy debates. As one of the world's leading innovative pharmaceutical companies, we support policies that improve patient access to quality care and enhance our ability to invest in innovation. Innovation comes in many forms — incremental, disruptive, breakthrough — and access to each form of innovation may benefit different patients in different ways.